Regeneron Pharmaceuticals, INC.
Pharmaceutical development and research company
Based in NY
🤖
AI Overview
With $1.8M in lobbying spend across 18 quarterly filings, Regeneron Pharmaceuticals, INC. is a significant lobbying presence. They deploy 14 individual lobbyists
$1.8M
Total Lobbying Spend
18
Quarterly Filings
1
Lobbying Firms Used
14
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $450K |
| 2019 | $460K |
| 2020 | $170K |
| 2021 | $500K |
| 2022 | $170K |
Lobbying Firms
VENN STRATEGIES
What They Lobby For
- General issues related to the bio-pharmaceutical sector, innovation, and health care manufacturing.
- Tax issues affecting publicly traded biotechnology companies.
- General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing.
- Tax issues affecting publicly traded biotechnology companies
- General issues related to the bio-pharmaceutical sector, innovation, patient access, and health care manufacturing. Also, in response to in response to the coronavirus pandemic, issues related to the strategic national stockpile and the COVID rescue packages.
- General issues related to the bio-pharmaceutical sector, innovation, patient access, health care manufacturing, and pandemic preparedness/response.
- Measures related to U.S. international and corporate tax policy.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.